Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease (CKD)

Sponsor
Minneapolis Veterans Affairs Medical Center (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT01446029
Collaborator
(none)
601
1
2
19
31.6

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if the adoption of a chronic care model in conjunction with tele monitoring and case management can reduce the risk of death, hospitalization, emergency room visits, or admission to a skilled nursing facility in patients with chronic kidney disease compared to usual care.

Condition or Disease Intervention/Treatment Phase
  • Device: Video Telemonitoring Device with Clinical Care Modules
Phase 3

Detailed Description

Chronic kidney disease (CKD) is a major public health issue. Approximately, 11% of the US population has CKD with an increased prevalence among individuals great than 65years. Many individuals with CKD go unrecognized because they are typically asymptomatic. Individuals with CKD have been demonstrated to have a greater risk for mortality, hospitalization and development of end stage kidney disease. Also, individuals with CKD consume a significantly greater proportion of health care expenditures compared to other patients. This study aims to determine if the adoption of a chronic care model in conjunction with telemonitoring and case management can reduce risk of death, hospitalization, ER visits or admission to a skilled nursing facility in patients with CKD compared to usual care. This study will use a randomized controlled trial. Few interventions have been demonstrated to improve clinical outcomes in patients with CKD. If successful, this study will enable the VA to provide high quality care to patients with CKD while potentially reducing the cost of providing care.

Study Design

Study Type:
Interventional
Actual Enrollment :
601 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease
Study Start Date :
Mar 1, 2012
Actual Primary Completion Date :
Oct 1, 2013
Actual Study Completion Date :
Oct 1, 2013

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual Care

Active Comparator: Intervention Device

Device: Video Telemonitoring Device with Clinical Care Modules
Telemonitoring of vital signs; videoconferencing, remote titration of diabetes, blood pressure, and lipid medications using evidence based treatment algorithm, and cooperative goal setting using education modules to enhance lifestyle changes
Other Names:
  • Telehealth
  • Telemonitoring
  • Chronic Disease Management
  • Outcome Measures

    Primary Outcome Measures

    1. composite clinical outcome (reduce risk of death, hospitalization, emergency room visits, admission to skilled nursing facility) [one year]

    Secondary Outcome Measures

    1. reduction of cost [one year]

    2. incidence of end stage kidney disease [one year]

    3. hospital re-admission [one year]

    4. Intervention group achieving National Kidney guideline values for blood pressure, glycemia, lipids, and hemoglobin [one year]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Inclusion Criteria: Enrolled at Minneapolis or St. Cloud Veterans Affairs Health Care System (VAHCS) or affiliated Community Based Outcomes Clinic(CBOC); Late eGFR within the VA system <60 ml/min/1.73m2 -

    Exclusion Criteria: Primary care provider unwilling to have participant included in study; unable to give consent; severe mental health condition; living in a nursing home

    -

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 VA Medical Center Minneapolis Minnesota United States 55417

    Sponsors and Collaborators

    • Minneapolis Veterans Affairs Medical Center

    Investigators

    • Principal Investigator: Areef Ishani, MD, US Department of Veterans Affairs

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Areef Ishani, Chief, Section of Nephrology; Associate Professor of Medicine, Minneapolis Veterans Affairs Medical Center
    ClinicalTrials.gov Identifier:
    NCT01446029
    Other Study ID Numbers:
    • Minn-VAMC-4292-A
    First Posted:
    Oct 4, 2011
    Last Update Posted:
    Aug 4, 2014
    Last Verified:
    Aug 1, 2014
    Keywords provided by Areef Ishani, Chief, Section of Nephrology; Associate Professor of Medicine, Minneapolis Veterans Affairs Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 4, 2014